Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation. - Wikidata - thesis-toulmin - TriplyDB

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

http://www.wikidata.org/entity/Q37525315

about

Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?

P2860

Q50536698-A65A92F9-4866-4CE4-AE67-18192FD6D2DF

P2860

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

http://www.wikidata.org/entity/Q37525315

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

@en

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

@nl

type

label

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

@en

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

@nl

prefLabel

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

@en

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

@nl

P1433

Q37525315-1198013F-0D0F-42DF-BEB5-65B051923130

P1476

Q37525315-D28A8FBC-1963-4819-8B81-E7D84CEE6C24

P2093

Q37525315-77C52657-A7E9-442C-9EA7-FCE422849F10

Q37525315-8F7C88AF-6C18-448E-99E5-8959DA1A8CF7

Q37525315-9C5F5609-4219-4F56-8D43-2229378BF941

Q37525315-A57A4F3B-D060-49F8-A342-ADCD50FBA14D

Q37525315-C1D08D5A-C10E-426E-A2A3-F5AF2F1F06A8

P2860

Q37525315-238A5B13-9026-46FE-A876-76E4734A1E19

Q37525315-2ACB99F9-E57F-4674-84A2-44FCE566D4CA

Q37525315-35AAC72D-BCBC-4AAD-8D57-C16561B5BD6E

Q37525315-3F9FCAD1-A48D-42C9-9AB7-8F626F0A1280

Q37525315-559E6BF3-8FBC-45F6-85F0-5D78D07974C3

Q37525315-62366A74-6869-4355-B71D-3B8E2CF83ECF

Q37525315-694A0512-20DA-4484-8A09-69EF234EDF1E

Q37525315-6D292CBA-92B6-45CA-909D-66EE477FBA29

Q37525315-87E98A2E-0862-4647-A030-43A6267CB51F

Q37525315-BBDF5490-D009-45E0-A9CE-EDE0F4BE3700

P304

Q37525315-B1F0AFE1-FE02-4BA6-8249-13EE8B770CD8

P31

Q37525315-262B54D8-1212-4164-894A-C09DC4CC32BF

P356

Q37525315-AEDC7AED-E64F-4153-94DD-0266CDB7D1CB

P433

Q37525315-D3229569-CC64-4713-8B31-36A41B6A0030

P478

Q37525315-8891E6E9-230E-4C20-A937-82632F6E0BFD

P577

Q37525315-336FAC28-135F-4F46-882B-E030D1BF8E28

P698

Q37525315-4864A3D6-63CA-468F-8EBA-71FC4FEB5189

P921

Q37525315-7B385FE7-2D3E-4D83-B243-2FF0AD007460

P932

Q37525315-2929BA85-A1A4-4B7B-B1D5-C3A2EFC4A1DB

P356

P1433

Journal of gastrointestinal oncology

P1476

Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation.

@en

P2093

Brian J Kaplan

http://www.w3.org/2001/XMLSchema#string

Emma C Fields

http://www.w3.org/2001/XMLSchema#string

Jennifer Myers

http://www.w3.org/2001/XMLSchema#string

Justin D Anderson

http://www.w3.org/2001/XMLSchema#string

Wen Wan

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

Neoadjuvant therapy for pancreas cancer: past lessons and future therapies

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.

A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Resection margins and R1 rates in pancreatic cancer--are we there yet?

Redefining resection margin status in pancreatic cancer

P304

1004-1010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JGO.2016.11.09

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28078125

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5177577

http://www.w3.org/2001/XMLSchema#string